ArticleDiabetologia2015

A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.

Pär G Larsson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.